Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,334
datasets available to search
ShareScore release 0.9.0
Dataset results
1,334 results for “Hematology”
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease
ClinicalTrials.gov study NCT00719888. IPD Sharing: NO. Countries: 1. Publications: 0.
High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors
ClinicalTrials.gov study NCT00536601. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Protocol For Genomically Profiling, Collecting, Archiving And Distributing Blood And Bone Marrow Specimens From Children And Young Adults With Hematologic Malignancy
ClinicalTrials.gov study NCT04968834. IPD Sharing: YES. Countries: 1. Publications: 0.
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
ClinicalTrials.gov study NCT02722668. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer
ClinicalTrials.gov study NCT00782379. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical Donor
ClinicalTrials.gov study NCT01982682. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Stem Cell Transplantation for Hematological Malignancies
ClinicalTrials.gov study NCT00176839. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a
ClinicalTrials.gov study NCT01794299. IPD Sharing: NO. Countries: 4. Publications: 0.
Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases
ClinicalTrials.gov study NCT02248597. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer
ClinicalTrials.gov study NCT00963872. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematolog
ClinicalTrials.gov study NCT03849651. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
ClinicalTrials.gov study NCT00448201. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies
ClinicalTrials.gov study NCT01499147. IPD Sharing: YES. Countries: 1. Publications: 0.
Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies
ClinicalTrials.gov study NCT01789255. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
ClinicalTrials.gov study NCT01093586. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies
ClinicalTrials.gov study NCT02362035. IPD Sharing: YES. Countries: 1. Publications: 0.
Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer
ClinicalTrials.gov study NCT00365287. IPD Sharing: Not stated. Countries: 0. Publications: 3.
Trial of Pimasertib in Hematological Malignancies
ClinicalTrials.gov study NCT00957580. IPD Sharing: Not stated. Countries: 2. Publications: 0.
GTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological Malignancies
ClinicalTrials.gov study NCT03214666. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
ClinicalTrials.gov study NCT01839916. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.